Lars Jønson

3.3k total citations
36 papers, 1.5k citations indexed

About

Lars Jønson is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Lars Jønson has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Genetics and 7 papers in Cancer Research. Recurrent topics in Lars Jønson's work include BRCA gene mutations in cancer (12 papers), CRISPR and Genetic Engineering (9 papers) and DNA Repair Mechanisms (6 papers). Lars Jønson is often cited by papers focused on BRCA gene mutations in cancer (12 papers), CRISPR and Genetic Engineering (9 papers) and DNA Repair Mechanisms (6 papers). Lars Jønson collaborates with scholars based in Denmark, United States and Greenland. Lars Jønson's co-authors include Thomas van Overeem Hansen, Finn Cilius Nielsen, Jan Christiansen, Jonas Vikesaa, Ulla M. Wewer, Rehannah Borup, Anders H. Johnsen, Bent Ejlertsen, T. Falk and Finn C. Nielsen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and European Journal of Biochemistry.

In The Last Decade

Lars Jønson

36 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Jønson Denmark 21 878 338 256 214 184 36 1.5k
Manuel Navarro Spain 20 766 0.9× 354 1.0× 113 0.4× 300 1.4× 186 1.0× 40 1.3k
Philippa Carr United Kingdom 9 1.7k 1.9× 281 0.8× 434 1.7× 322 1.5× 260 1.4× 12 2.8k
Ruth Padmore Canada 16 1.6k 1.8× 237 0.7× 218 0.9× 214 1.0× 129 0.7× 45 2.3k
María Jiménez Spain 20 903 1.0× 667 2.0× 163 0.6× 529 2.5× 338 1.8× 29 1.9k
Susanne Popp Germany 20 912 1.0× 373 1.1× 647 2.5× 393 1.8× 87 0.5× 36 1.8k
Charbel Darido Australia 21 1.1k 1.3× 309 0.9× 313 1.2× 409 1.9× 132 0.7× 47 1.7k
Marius Teletin France 18 826 0.9× 97 0.3× 245 1.0× 93 0.4× 271 1.5× 33 1.3k
Zhila Khalkhali‐Ellis United States 22 671 0.8× 524 1.6× 169 0.7× 372 1.7× 156 0.8× 41 1.4k
Diana C. Blaydon United Kingdom 18 846 1.0× 98 0.3× 293 1.1× 169 0.8× 155 0.8× 29 1.6k
Gerhard Regl Austria 16 1.5k 1.7× 89 0.3× 332 1.3× 482 2.3× 86 0.5× 19 1.8k

Countries citing papers authored by Lars Jønson

Since Specialization
Citations

This map shows the geographic impact of Lars Jønson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Jønson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Jønson more than expected).

Fields of papers citing papers by Lars Jønson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Jønson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Jønson. The network helps show where Lars Jønson may publish in the future.

Co-authorship network of co-authors of Lars Jønson

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Jønson. A scholar is included among the top collaborators of Lars Jønson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Jønson. Lars Jønson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Ane Yde, Thomas van Overeem Hansen, Lise Barlebo Ahlborn, et al.. (2017). Next-Generation Sequencing–Based Detection of Germline Copy Number Variations in BRCA1 / BRCA2. Journal of Molecular Diagnostics. 19(6). 809–816. 20 indexed citations
2.
Jønson, Lars, Lise Barlebo Ahlborn, Bent Ejlertsen, et al.. (2016). Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer. Breast Cancer Research and Treatment. 155(2). 215–222. 22 indexed citations
3.
Nazaryan‐Petersen, Lusine, Birgitte Bertelsen, Mads Bak, et al.. (2016). Germline Chromothripsis Driven by L1-Mediated Retrotransposition and Alu/Alu Homologous Recombination. Human Mutation. 37(4). 385–395. 42 indexed citations
4.
Leinøe, Eva, Ove Juul Nielsen, Lars Jønson, & Maria Rossing. (2016). Whole-exome sequencing of a patient with severe and complex hemostatic abnormalities reveals a possible contributing frameshift mutation in C3AR1. Molecular Case Studies. 2(4). a000828–a000828. 8 indexed citations
5.
Ahlborn, Lise Barlebo, et al.. (2014). Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations. Familial Cancer. 14(1). 129–133. 12 indexed citations
6.
Jønson, Lars, Jan Christiansen, Thomas van Overeem Hansen, et al.. (2014). IMP3 RNP Safe Houses Prevent miRNA-Directed HMGA2 mRNA Decay in Cancer and Development. Cell Reports. 7(2). 539–551. 75 indexed citations
7.
Jønson, Lars, et al.. (2014). Functional characterization of BRCA1 gene variants by mini-gene splicing assay. European Journal of Human Genetics. 22(12). 1362–1368. 48 indexed citations
8.
Kopp, Katharina, Ulrik Ralfkiær, Lise Mette Rahbek Gjerdrum, et al.. (2013). STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. Cell Cycle. 12(12). 1939–1947. 112 indexed citations
9.
Hansen, Thomas van Overeem, Lars Jønson, Mette Klarskov Andersen, et al.. (2011). Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutations. Familial Cancer. 10(2). 207–212. 3 indexed citations
11.
Jønson, Lars, Finn Cilius Nielsen, & Jan Christiansen. (2010). Isolation of RNP Granules. Methods in molecular biology. 703. 265–273. 3 indexed citations
12.
Hansen, Thomas van Overeem, et al.. (2009). The silent mutation nucleotide 744 G → A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping. Breast Cancer Research and Treatment. 119(3). 547–550. 24 indexed citations
13.
Hansen, Thomas van Overeem, Marie Luise Bisgaard, Lars Jønson, et al.. (2008). Novel de novo BRCA2mutation in a patient with a family history of breast cancer. BMC Medical Genetics. 9(1). 58–58. 33 indexed citations
14.
Hansen, Thomas van Overeem, Bent Ejlertsen, Anders Albrechtsen, et al.. (2008). A common Greenlandic Inuit BRCA1 RING domain founder mutation. Breast Cancer Research and Treatment. 115(1). 69–76. 18 indexed citations
15.
Voorst, Frank van, et al.. (2006). Genome‐wide identification of genes required for growth of Saccharomyces cerevisiae under ethanol stress. Yeast. 23(5). 351–359. 127 indexed citations
16.
Vikesaa, Jonas, Thomas van Overeem Hansen, Lars Jønson, et al.. (2006). RNA‐binding IMPs promote cell adhesion and invadopodia formation. The EMBO Journal. 25(7). 1456–1468. 285 indexed citations
17.
Jønson, Lars, Jens F. Rehfeld, & Anders H. Johnsen. (2004). Enhanced peptide secretion by gene disruption of CYM1, a novel protease in Saccharomyces cerevisiae. European Journal of Biochemistry. 271(23-24). 4788–4797. 23 indexed citations
18.
Jensen, Hanne, Ian J. Rourke, Morten Møller, Lars Jønson, & Anders H. Johnsen. (2001). Identification and distribution of CCK-related peptides and mRNAs in the rainbow trout, Oncorhynchus mykiss. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1517(2). 190–201. 55 indexed citations
19.
Jønson, Lars, et al.. (2000). Identification of ostrich and chicken cholecystokinin cDNA and intestinal peptides☆. Peptides. 21(9). 1337–1344. 13 indexed citations
20.
Falk, T. & Lars Jønson. (2000). Ischaemic heart disease in the dog: a review of 65 cases. Journal of Small Animal Practice. 41(3). 97–103. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026